• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于可溶性fms样酪氨酸激酶1(sFlt-1)/胎盘生长因子(PlGF)比值和子宫多普勒超声对有风险女性妊娠中期早发型高血压疾病发生及严重程度的预测算法

A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk.

作者信息

Chirilă Cristian Nicolae, Mărginean Claudiu, Ghiga Dana Valentina, Voidăzan Septimiu, Chirilă Paula Maria, Gliga Mirela Liana

机构信息

Department of Internal Medicine-Nephrology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania.

Department of Nephrology, Mures Clinical County Hospital, 540103 Târgu Mureș, Romania.

出版信息

Children (Basel). 2024 Apr 14;11(4):468. doi: 10.3390/children11040468.

DOI:10.3390/children11040468
PMID:38671685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11049313/
Abstract

Hypertensive disorders of pregnancy (HDPs) represent a significant source of severe maternal and fetal morbidity. Screening strategies relying on traditional medical history and clinical risk factors have traditionally shown relatively modest performance, mainly in the prediction of preeclampsia, displaying a sensitivity of 37% for the early-onset form and 29% for the late-onset form. The development of more accurate predictive and diagnostic models of preeclampsia in the early stages of pregnancy represents a matter of high priority. The aim of the present paper is to create an effective second trimester prediction algorithm of early-onset HDP occurrence and severity, by combining the following two biochemical markers: a soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio and uterine artery Doppler ultrasound parameters, namely the pulsatility index (PI) and the resistivity index (RI), in a population of high-risk pregnant women, initially assessed through traditional risk factors. A prospective single-center observational longitudinal study was conducted, in which 100 women with singleton pregnancy and traditional clinical and medical history risk factors for preeclampsia were enrolled at 24 weeks of gestation. Shortly after study enrollment, all women had their sFlt-1 and PlGF levels and mean uterine artery PI and RI determined. All pregnancies were followed up until delivery. Receiver operating characteristic (ROC) analysis established algorithms based on cutoffs for the prediction of the later development of preeclampsia: PI 1.25 (96.15% sensitivity, 86.49% specificity), RI 0.62 (84.6% sensitivity, 89.2% specificity) and sFlt-1/PlGF ratio 59.55 (100% sensitivity, 89.2% specificity). The sFlt-1/PlGF ratio was the best predictor for preeclampsia, as it displayed the highest area under the curve (AUC) of 0.973. The prediction algorithm for the severe form of preeclampsia, complicated by fetal growth restriction leading to preterm birth, antepartum fetal demise or acute fetal distress with a cerebro-placental ratio of <one consisted of the following cutoffs: PI 1.44 (93.75% sensitivity, 95.24% specificity), RI 0.69 (87.5% sensitivity, 100% specificity) and sFlt-1/PlGF ratio 102.74 (93.75% sensitivity, 95.2% specificity). These algorithms may significantly enhance the prediction accuracy of preeclampsia compared to traditional risk factors. The combination of the sFlt-1/PlGF ratio with mean uterine PI and RI in particular displayed an improved performance in the prediction of severe preeclampsia with the above-mentioned complications, compared to the biochemical markers or uterine Doppler parameters used alone. Therefore, HDP screening strategies should increasingly focus on implementing such algorithms for women who are initially regarded as high risk based on traditional risk factors, in order to properly diagnose HDP and properly limit or manage the later maternal and fetal complications.

摘要

妊娠期高血压疾病(HDPs)是严重孕产妇和胎儿发病的重要原因。传统上,依靠传统病史和临床风险因素的筛查策略表现相对一般,主要用于预测先兆子痫,早发型先兆子痫的敏感性为37%,晚发型先兆子痫的敏感性为29%。在妊娠早期开发更准确的先兆子痫预测和诊断模型是当务之急。本文的目的是通过结合以下两种生化标志物,在一组最初通过传统风险因素评估的高危孕妇中,创建一种有效的孕中期早发型HDP发生及严重程度的预测算法:可溶性fms样酪氨酸激酶1(sFlt-1)/胎盘生长因子(PlGF)比值和子宫动脉多普勒超声参数,即搏动指数(PI)和阻力指数(RI)。进行了一项前瞻性单中心观察性纵向研究,在妊娠24周时纳入了100名单胎妊娠且有先兆子痫传统临床和病史风险因素的妇女。研究入组后不久,测定了所有妇女的sFlt-1和PlGF水平以及子宫动脉平均PI和RI。所有妊娠均随访至分娩。受试者工作特征(ROC)分析基于预测先兆子痫后期发展的临界值建立了算法:PI为1.25(敏感性96.15%,特异性86.49%),RI为0.62(敏感性84.6%,特异性89.2%),sFlt-1/PlGF比值为59.55(敏感性100%,特异性89.2%)。sFlt-1/PlGF比值是先兆子痫的最佳预测指标,因为它显示出最高的曲线下面积(AUC)为0.973。重度先兆子痫的预测算法,伴有因胎儿生长受限导致早产、产前胎儿死亡或急性胎儿窘迫且脑胎盘比值<1,其临界值如下:PI为1.44(敏感性93.75%,特异性95.24%),RI为0.69(敏感性87.5%,特异性100%),sFlt-1/PlGF比值为102.74(敏感性93.75%,特异性95.2%)。与传统风险因素相比,这些算法可能会显著提高先兆子痫的预测准确性。特别是sFlt-1/PlGF比值与子宫动脉平均PI和RI的组合,与单独使用生化标志物或子宫多普勒参数相比,在预测伴有上述并发症的重度先兆子痫方面表现出更好的性能。因此,HDP筛查策略应越来越多地关注为那些基于传统风险因素最初被视为高危的女性实施此类算法,以便正确诊断HDP并适当限制或管理后期的孕产妇和胎儿并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/582f538eb017/children-11-00468-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/eb911c4fb79e/children-11-00468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/68b69e7dcf46/children-11-00468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/b246036b4714/children-11-00468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/f6152376bb58/children-11-00468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/adf1c26e1cc0/children-11-00468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/baf54a6b0d17/children-11-00468-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/ee56fd5e3730/children-11-00468-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/5869e8932442/children-11-00468-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/582f538eb017/children-11-00468-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/eb911c4fb79e/children-11-00468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/68b69e7dcf46/children-11-00468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/b246036b4714/children-11-00468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/f6152376bb58/children-11-00468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/adf1c26e1cc0/children-11-00468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/baf54a6b0d17/children-11-00468-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/ee56fd5e3730/children-11-00468-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/5869e8932442/children-11-00468-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4cc/11049313/582f538eb017/children-11-00468-g009.jpg

相似文献

1
A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk.基于可溶性fms样酪氨酸激酶1(sFlt-1)/胎盘生长因子(PlGF)比值和子宫多普勒超声对有风险女性妊娠中期早发型高血压疾病发生及严重程度的预测算法
Children (Basel). 2024 Apr 14;11(4):468. doi: 10.3390/children11040468.
2
The Current Role of the sFlt-1/PlGF Ratio and the Uterine-Umbilical-Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature.可溶性血管内皮生长因子受体-1/胎盘生长因子比值及子宫-脐-脑多普勒超声在预测和监测妊娠高血压疾病中的当前作用:文献综述与更新
Children (Basel). 2023 Aug 22;10(9):1430. doi: 10.3390/children10091430.
3
Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.印度人群中可溶性血管内皮生长因子受体1/胎盘生长因子比值与子痫前期严重程度的相关性
AJOG Glob Rep. 2023 Feb 7;3(2):100177. doi: 10.1016/j.xagr.2023.100177. eCollection 2023 May.
4
Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.sFlt-1/PlGF 比值和胎儿-母亲多普勒血流检测预测晚发型子痫前期不良围生结局的作用。
Arch Gynecol Obstet. 2020 Feb;301(2):375-385. doi: 10.1007/s00404-019-05365-9. Epub 2019 Nov 16.
5
Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.胎盘、胎儿及母体心血管标志物在预测疑似或确诊子痫前期女性不良结局中的作用
Ultrasound Obstet Gynecol. 2022 May;59(5):596-605. doi: 10.1002/uog.24851.
6
Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.单独或联合使用胎盘生长因子、可溶性 fms 样酪氨酸激酶-1 或母体因素在第二和第三孕期无症状妇女中检测子痫前期的准确性:系统评价和荟萃分析。
Am J Obstet Gynecol. 2023 Sep;229(3):222-247. doi: 10.1016/j.ajog.2023.03.032. Epub 2023 Mar 28.
7
Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy.血管生成和心血管生物标志物对早孕期胎盘功能障碍预测的影响
Biomedicines. 2023 Apr 29;11(5):1327. doi: 10.3390/biomedicines11051327.
8
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.使用多种标志物的筛查模型用于低风险妊娠中晚发型子痫前期的早期检测。
BMC Pregnancy Childbirth. 2014 Jan 20;14:35. doi: 10.1186/1471-2393-14-35.
9
Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 可作为预测子痫前期的有用标志物,但不能作为预测小于胎龄儿的标志物:一项纵向研究。
Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):225-30. doi: 10.1016/j.ejogrb.2013.08.040. Epub 2013 Sep 4.
10
Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.联合生物标志物预测妊娠并发症并重新定义子痫前期:血管生成-胎盘综合征
Hypertension. 2020 Apr;75(4):918-926. doi: 10.1161/HYPERTENSIONAHA.119.13763. Epub 2020 Feb 17.

引用本文的文献

1
Could Low Serum Albumin Level Be an Independent Marker of Severe Preeclampsia?低血清白蛋白水平会是重度子痫前期的独立标志物吗?
Healthcare (Basel). 2025 Jun 24;13(13):1503. doi: 10.3390/healthcare13131503.

本文引用的文献

1
The Current Role of the sFlt-1/PlGF Ratio and the Uterine-Umbilical-Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature.可溶性血管内皮生长因子受体-1/胎盘生长因子比值及子宫-脐-脑多普勒超声在预测和监测妊娠高血压疾病中的当前作用:文献综述与更新
Children (Basel). 2023 Aug 22;10(9):1430. doi: 10.3390/children10091430.
2
Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes.血清尿酸肌酐比值与子痫前期及不良妊娠结局的关系。
J Hypertens. 2023 Aug 1;41(8):1333-1338. doi: 10.1097/HJH.0000000000003472. Epub 2023 Jun 5.
3
Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management.
可溶性胎儿纤维连接蛋白-1与胎盘生长因子比值在子痫前期恰当管理中的应用价值
Healthcare (Basel). 2023 Jan 29;11(3):381. doi: 10.3390/healthcare11030381.
4
Preeclampsia Incidence and Its Maternal and Neonatal Outcomes With Associated Risk Factors.子痫前期的发病率及其母婴结局与相关危险因素
Cureus. 2022 Nov 6;14(11):e31143. doi: 10.7759/cureus.31143. eCollection 2022 Nov.
5
Reference ranges of uterine artery pulsatility index from first to third trimester based on serial Doppler measurements: longitudinal cohort study.基于连续多普勒测量的早、中孕期子宫动脉搏动指数参考范围:纵向队列研究。
Ultrasound Obstet Gynecol. 2023 Apr;61(4):474-480. doi: 10.1002/uog.26092.
6
Abnormal uterine artery Doppler ultrasound during gestational 21-23 weeks associated with pre-eclampsia.妊娠21 - 23周时子宫动脉多普勒超声异常与子痫前期相关。
Int J Gynaecol Obstet. 2023 Apr;161(1):264-270. doi: 10.1002/ijgo.14435. Epub 2022 Sep 21.
7
Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.sFlt-1 和 PlGF 在子痫前期和胎儿生长受限的筛查、预测、诊断和监测中的临床应用。
Ultrasound Obstet Gynecol. 2023 Feb;61(2):168-180. doi: 10.1002/uog.26032.
8
The clinical value of PlGF and the sFlt1/PlGF ratio in the management of hypertensive pregnancy disorders: A retrospective real-world study in China.胎盘生长因子和可溶性 fms 样酪氨酸激酶 1/胎盘生长因子比值在高血压妊娠疾病管理中的临床价值:中国的回顾性真实世界研究。
Clin Chim Acta. 2022 Mar 1;528:90-97. doi: 10.1016/j.cca.2022.01.021. Epub 2022 Jan 29.
9
Assessing the Role of Uric Acid as a Predictor of Preeclampsia.评估尿酸作为子痫前期预测指标的作用。
Front Physiol. 2022 Jan 13;12:785219. doi: 10.3389/fphys.2021.785219. eCollection 2021.
10
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice.2021 年国际妊娠高血压学会分类、诊断与管理国际实践推荐建议。
Pregnancy Hypertens. 2022 Mar;27:148-169. doi: 10.1016/j.preghy.2021.09.008. Epub 2021 Oct 9.